• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用纵向电子健康记录,基于深度学习预测抗生素引起的艰难梭菌感染

Deep learning-based prediction of Clostridioides difficile infection caused by antibiotics using longitudinal electronic health records.

作者信息

Kim Junmo, Kim Joo Seong, Kim Sae-Hoon, Yoo Sooyoung, Lee Jun Kyu, Kim Kwangsoo

机构信息

Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, Republic of Korea.

Division of Gastroenterology, Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Republic of Korea.

出版信息

NPJ Digit Med. 2024 Aug 24;7(1):224. doi: 10.1038/s41746-024-01215-4.

DOI:10.1038/s41746-024-01215-4
PMID:39181992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11344761/
Abstract

Clostridioides difficile infection (CDI) is a major cause of antibiotic-associated diarrhea and colitis. It is recognized as one of the most significant hospital-acquired infections. Although CDI can develop severe complications and spores of Clostridioides difficile can be transmitted by the fecal-oral route, CDI is occasionally overlooked in clinical settings. Thus, it is necessary to monitor high CDI risk groups, particularly those undergoing antibiotic treatment, to prevent complications and spread. We developed and validated a deep learning-based model to predict the occurrence of CDI within 28 days after starting antibiotic treatment using longitudinal electronic health records. For each patient, timelines of vital signs and laboratory tests with a 35-day monitoring period and a patient information vector consisting of age, sex, comorbidities, and medications were constructed. Our model achieved the prediction performance with an area under the receiver operating characteristic curve of 0.952 (95% CI: 0.932-0.973) in internal validation and 0.972 (95% CI: 0.968-0.975) in external validation. Platelet count and body temperature emerged as the most important features. The risk score, the output value of the model, exhibited a consistent increase in the CDI group, while the risk score in the non-CDI group either maintained its initial value or decreased. Using our CDI prediction model, high-risk patients requiring symptom monitoring can be identified. This could help reduce the underdiagnosis of CDI, thereby decreasing transmission and preventing complications.

摘要

艰难梭菌感染(CDI)是抗生素相关性腹泻和结肠炎的主要原因。它被认为是最重要的医院获得性感染之一。尽管CDI可引发严重并发症,且艰难梭菌孢子可通过粪-口途径传播,但在临床环境中CDI有时会被忽视。因此,有必要监测CDI高风险人群,尤其是正在接受抗生素治疗的人群,以预防并发症和传播。我们开发并验证了一种基于深度学习的模型,该模型利用纵向电子健康记录预测开始抗生素治疗后28天内CDI的发生情况。对于每位患者,构建了35天监测期内的生命体征和实验室检查时间线,以及由年龄、性别、合并症和用药情况组成的患者信息向量。我们的模型在内部验证中的受试者工作特征曲线下面积为0.952(95%CI:0.932 - 0.973),在外部验证中的受试者工作特征曲线下面积为0.972(95%CI:0.968 - 0.975),达到了预测性能。血小板计数和体温成为最重要的特征。风险评分作为模型的输出值,在CDI组中持续升高,而非CDI组的风险评分要么保持初始值,要么降低。使用我们的CDI预测模型,可以识别出需要进行症状监测的高危患者。这有助于减少CDI的漏诊,从而减少传播并预防并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5e/11344761/d249e9c07fcf/41746_2024_1215_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5e/11344761/0ca91d6cc7d7/41746_2024_1215_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5e/11344761/cbd73a633c59/41746_2024_1215_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5e/11344761/50194ed94c0b/41746_2024_1215_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5e/11344761/f9cabbed2b53/41746_2024_1215_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5e/11344761/a715423e792d/41746_2024_1215_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5e/11344761/d249e9c07fcf/41746_2024_1215_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5e/11344761/0ca91d6cc7d7/41746_2024_1215_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5e/11344761/cbd73a633c59/41746_2024_1215_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5e/11344761/50194ed94c0b/41746_2024_1215_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5e/11344761/f9cabbed2b53/41746_2024_1215_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5e/11344761/a715423e792d/41746_2024_1215_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5e/11344761/d249e9c07fcf/41746_2024_1215_Fig6_HTML.jpg

相似文献

1
Deep learning-based prediction of Clostridioides difficile infection caused by antibiotics using longitudinal electronic health records.利用纵向电子健康记录,基于深度学习预测抗生素引起的艰难梭菌感染
NPJ Digit Med. 2024 Aug 24;7(1):224. doi: 10.1038/s41746-024-01215-4.
2
Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.系统炎症介质是预测艰难梭菌感染不良结局的有效生物标志物。
mBio. 2020 May 5;11(3):e00180-20. doi: 10.1128/mBio.00180-20.
3
Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.粪便微生物群移植治疗复发性肠道艰难梭菌感染 - 十年单中心经验。
Cas Lek Cesk. 2022 Summer;161(3-4):126-130.
4
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.RBX2660 在 PUNCH CD3 中的疗效和安全性:一项 III 期、随机、双盲、安慰剂对照试验,采用贝叶斯主要分析预防复发性艰难梭菌感染。
Drugs. 2022 Oct;82(15):1527-1538. doi: 10.1007/s40265-022-01797-x. Epub 2022 Oct 26.
5
The role of the gut microbiome in colonization resistance and recurrent infection.肠道微生物群在定植抗性和反复感染中的作用。
Therap Adv Gastroenterol. 2022 Nov 18;15:17562848221134396. doi: 10.1177/17562848221134396. eCollection 2022.
6
SEASON GAP score: A predictor of Clostridioides difficile infection among patients with tube feeding.季节差距评分:预测管饲患者艰难梭菌感染的指标。
J Infect Chemother. 2022 Aug;28(8):1131-1137. doi: 10.1016/j.jiac.2022.04.011. Epub 2022 Apr 16.
7
Predictors of hospital-onset Clostridioides difficile infection in children with antibiotic-associated diarrhea.抗生素相关性腹泻患儿医院获得性艰难梭菌感染的预测因素
Am J Infect Control. 2023 Aug;51(8):879-883. doi: 10.1016/j.ajic.2022.12.004. Epub 2022 Dec 16.
8
Antimicrobial Activity of Tannic Acid and Its Protective Effect on Mice against Clostridioides difficile.没食子酸的抗菌活性及其对艰难梭菌感染小鼠的保护作用。
Microbiol Spectr. 2023 Feb 14;11(1):e0261822. doi: 10.1128/spectrum.02618-22. Epub 2022 Dec 20.
9
A new score to predict Clostridioides difficile infection in medical patients: a sub-analysis of the FADOI-PRACTICE study.一种预测医疗患者艰难梭菌感染的新评分:FADOI-PRACTICE 研究的亚分析。
Intern Emerg Med. 2023 Oct;18(7):2003-2009. doi: 10.1007/s11739-023-03395-5. Epub 2023 Aug 26.
10
A Prediction Model Incorporating Peripheral Eosinopenia as a Novel Risk Factor for Death After Hospitalization for Infection.一种将外周血嗜酸性粒细胞减少作为感染住院后死亡新危险因素的预测模型。
Gastro Hep Adv. 2022;1(1):38-44. doi: 10.1016/j.gastha.2021.10.002. Epub 2022 Feb 7.

本文引用的文献

1
Insights into the Evolving Epidemiology of Infection and Treatment: A Global Perspective.《感染与治疗的演变流行病学洞察:全球视角》
Antibiotics (Basel). 2023 Jul 1;12(7):1141. doi: 10.3390/antibiotics12071141.
2
A comparative analysis of machine learning approaches to predict C. difficile infection in hospitalized patients.机器学习方法预测住院患者艰难梭菌感染的比较分析。
Am J Infect Control. 2022 Mar;50(3):250-257. doi: 10.1016/j.ajic.2021.11.012. Epub 2022 Jan 20.
3
The Importance of Abnormal Platelet Count in Patients with Infection.
感染患者血小板计数异常的重要性
J Clin Med. 2021 Jun 30;10(13):2957. doi: 10.3390/jcm10132957.
4
A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea.艰难梭菌感染与抗生素相关性腹泻综述
Gastroenterol Clin North Am. 2021 Jun;50(2):323-340. doi: 10.1016/j.gtc.2021.02.010.
5
Hospitalized patients with diarrhea: Rate of Clostridioides difficile infection underdiagnosis and drivers of clinical suspicion.腹泻住院患者:艰难梭菌感染漏诊率及临床怀疑的驱动因素。
Anaerobe. 2021 Aug;70:102380. doi: 10.1016/j.anaerobe.2021.102380. Epub 2021 May 7.
6
Modest Clostridiodes difficile infection prediction using machine learning models in a tertiary care hospital.使用机器学习模型在三级保健医院进行适度艰难梭菌感染预测。
Diagn Microbiol Infect Dis. 2020 Oct;98(2):115104. doi: 10.1016/j.diagmicrobio.2020.115104. Epub 2020 Jun 8.
7
Trends in U.S. Burden of Infection and Outcomes.美国感染负担和结局的趋势。
N Engl J Med. 2020 Apr 2;382(14):1320-1330. doi: 10.1056/NEJMoa1910215.
8
Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis.艰难梭菌感染的发生率和结局:系统评价和荟萃分析。
JAMA Netw Open. 2020 Jan 3;3(1):e1917597. doi: 10.1001/jamanetworkopen.2019.17597.
9
Clostridium difficile infection: review.艰难梭菌感染:综述。
Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1211-1221. doi: 10.1007/s10096-019-03539-6. Epub 2019 Apr 3.
10
Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Infections.粪便微生物群移植治疗感染成功的机制性见解
Front Microbiol. 2018 Jun 12;9:1242. doi: 10.3389/fmicb.2018.01242. eCollection 2018.